TOVX Theriva Biologics, Inc.
0.2340USD+5.41%Mkt Cap: 10.74M $P/E: 0.321d ago
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepve…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap10.74M USD
Enterprise Value2.40M USD
Revenue (TTM)300.00K USD
Gross Profit300.00K USD
Net Income (TTM)-23.74M USD
Revenue/Share0.01 USD
Last Price0.2340 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.32
P/E (Forward)-1.11
PEG—
EV/EBITDA-0.20
EV/Revenue8.01
P/S33.96
P/B0.83
EPS (TTM)0.73
EPS (Forward)-0.20
52W Range
0.160011% of range0.8600
52W High0.8600 USD
52W Low0.1600 USD
Profitability
Gross Margin100.00%
Oper. Margin-4022.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-154.32%
ROA-62.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.67M USD
CapEx (TTM)35.00K USD
FCF Margin-2231.42%
FCF Yield-62.34%
Net Debt-7.78M USD
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.17
Current Ratio1.13
Quick Ratio1.08
Book Value/Sh0.27 USD
Cash/Share0.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 13, 2018
Splits
Last Split1:25
Split DateAug 26, 2024
Analyst Consensus
Rating—
Target (Mean)2.500 USD
Upside (mean)+968.4%
Target Range1.000 USD – 4.000 USD
1.000+968.4% to mean4.000
# Analysts2
Ownership
Shares Out.45.89M
Float45.15M
Insiders1.63%
Institutions4.32%
Short Interest
Short Ratio2.9d
Short % Float3.46%
Short % Out.3.46%
Shares Short1.59M
Short (prev mo.)1.72M
Technical
SMA 500.2326 (+0.6%)
SMA 2000.2399 (-2.5%)
Beta1.19
S&P 52W Chg16.45%
Avg Vol (30d)478.01K
Avg Vol (10d)448.47K
Technical Indicators
RSI (14)53.1
MACD-0.0031
MACD Signal-0.0032
MACD Hist.+0.0001
BB Upper0.2527 USD
BB Middle0.2310 USD
BB Lower0.2092 USD
BB Width18.86%
ATR (14)0.0134 USD
Vol Ratio (20d)1.90x